HealthCap | Activity | F4

Team Portfolio Raise Essays

F4/HealthCap/Activity

HealthCap Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Press

Nordic Life Science publishes in-depth profile interview with HealthCap co-founder Björn Odlander on the firm's 30-year approach to life science investing, its portfolio track record, and Europe's capital gap.

Björn Odlander interviewed on HealthCap's 30-year journey

nordiclifescience.orgSEP 24, 2026

SEP 24, 2026

Talk

HealthCap highlighted Hemab presenting new clinical data and introducing HMB-003 at ISTH 2026.

Hemab Therapeutics

Hemab Therapeutics HealthCap

healthcap.euJUL 12, 2026

JUL 12, 2026

Investment

HealthCap participated in CurifyLabs' €12 million Series A round alongside Sandwater and other investors. CurifyLabs is a Finnish healthtech company.

CurifyLabs

CurifyLabs HealthCap

startuprise.co.ukJUL 6, 2026

JUL 6, 2026

Investment

HealthCap led the investment in Neobiomics to support continued growth in neonatal care.

Neobiomics

Neobiomics HealthCap

healthcap.euMAY 20, 2026

MAY 20, 2026

Exit

Hemab Therapeutics, a HealthCap portfolio company, listed on NASDAQ at a market cap of $764M.

Hemab Therapeutics

Hemab Therapeutics HealthCap

tracxn.comMAY 1, 2026

MAY 1, 2026

News

Intervacc announced that Jonas Sohlman would leave as CEO and Carl-Johan Dalsgaard was appointed CEO.

Intervacc

Intervacc HealthCap

healthcap.euFEB 5, 2026

FEB 5, 2026

Investment

HealthCap joined the SEK 347 million Series B second closing of Gesynta Pharma, alongside Hadean Growth Fund and led by Innovestor Life Science. HealthCap partner Kristina Ekberg appointed to the board.

Gesynta Pharma

Gesynta Pharma HealthCap

gesynta.seJUL 22, 2025

JUL 22, 2025

New Fund

Novo Holdings and the Danish Export and Investment Fund (EIFO) invested €48 million in HealthCap IX, HealthCap's ninth fund, to strengthen the Nordic life sciences ecosystem.

Novo Holdings and EIFO invest €48M in HealthCap IX

prnewswire.co.ukAPR 24, 2025

APR 24, 2025

Exit

Fusion Pharmaceuticals was acquired by AstraZeneca for up to USD 2.4 billion.

Fusion Pharmaceuticals

Fusion Pharmaceuticals HealthCap

healthcap.euMAR 19, 2024

MAR 19, 2024